Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial "CABANA"


Phase N/A Results

Summary of Purpose

The CABANA pilot study is designed to test the hypothesis that the treatment strategy of percutaneous left atrial catheter ablation for the purpose of the elimination of atrial fibrillation (AF) is superior to current state-of-the-art therapy with either rate control or anti-arrhythmic drugs for reducing AF recurrences at 1 year follow-up.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 December 2012.

1 Sep 2006 14 Dec 2007 1 Feb 2009 1 Jun 2010 1 Dec 2012 20 Jul 2011
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available